<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>14</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Why Substantial Budget Reallocations Are Not and Should Not Be a Major Factor in Active Purchasing in Dutch Healthcare; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>3</LastPage>
			<ELocationID EIdType="pii">4778</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.9115</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Fredo</FirstName>
					<LastName>Schotanus</LastName>
<Affiliation>School of Economics, Utrecht University, Utrecht, The Netherlands</Affiliation>
<Identifier Source="ORCID">0000-0001-5775-1225</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>26</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;This commentary discusses the study by Stadhouders et al, which analyzes budget reallocations among Dutch &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;healthcare providers as a result of one form of active purchasing. The study assumes that healthcare purchasers &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;aim to shift substantial funds from inefficient to efficient providers, yet finds little evidence of such shifts. This &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;commentary explains more explicitly why substantial volume shifts are not and should not be a major factor in the &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Dutch context, citing factors such as the scarcity of underperforming providers, strong regional dependencies, data &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;quality limitations, and patient reluctance to change provider. More promising avenues for active purchasing include &lt;/span&gt;&lt;span class=&quot;fontstyle0&quot;&gt;fostering active collaboration and improving contractual arrangements.&lt;/span&gt; </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Managed Competition</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Purchasing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Healthcare Reform</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">The Netherlands</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_4778_085ccaddbd3aa270b1d72beef6bbc5ca.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
